Description :
Nuclear medicine equipment utilize radioactive substances , which are introduced into the body either intravenously or orally in small quantities , to diagnosis and treat various diseases . These equipment create images by capturing the radiation from these radioactive medicines . This technique is used for early diagnosis of a disease , as it tracks the molecular activities within the body . In addition , it is used to examine immediate response to therapeutic interventions .
The global nuclear medicine equipment market is estimated to reach $ 2,647 million by 2022 from $ 2,012 million in 2015 , growing at a CAGR of 3.9 % from 2016 to 2022 . Increase in prevalence of cancer , heart-related diseases , and neurological disorders has given rise to the importance of early disease diagnosis , which is expected to positively impact the market growth . The nuclear medicine equipment market is driven by the availability of high-quality equipment , rise in adoption of nuclear medicine equipment , and emergence of innovative & advanced equipment . However , high cost of these equipment and their short half-life , high hospital expense , and high cost related to diagnostic imaging services hinder the market growth .
Browse the full report @ http :// www . orbisresearch . com / reports / index / nuclearmedicine-equipment-market-by-product-type-and-pet-application-and-end-user-globalopportunity-analysis-and-industry-forecast-2014-2022 .
The nuclear medicine equipment market is segmented based on product , application , end user , and geography . Based on product , the market is bifurcated into single-photon emission computed tomography ( SPECT ) and positron emission tomography ( PET ). SPECT is further segmented into standalone and hybrid SPECT , while PET into standalone and hybrid PET . By application , the market is categorized into cardiology , neurology , oncology , and others . Based on end user , it is classified into hospitals , imaging centers , and academic & research institutes . Geographically , it is analyzed across North America ( U . S ., Canada , and Mexico ), Europe ( Germany , France , UK , Italy , Spain , Russia , and rest of Europe ), Asia-Pacific ( Japan , China , Australia , India , and rest of Asia-Pacific ), and LAMEA ( Brazil , Turkey , Saudi Arabia , Republic of South Africa , Argentina , and rest of LAMEA ).
The key players in the industry have adopted product launch as their key developmental strategy to expand their market foothold . For instance , in November 2016 , Philips launched an advanced visual analysis and quantification platform called IntelliSpace Portal 9.0 ., which assists radiologists to diagnose and monitor the treatment of neurological diseases , such as multiple sclerosis and dementia .
Check the DISCOUNT on this report @ http :// www . orbisresearch . com / contacts / discount / 214289 .
Key market benefits : This report provides a detailed quantitative analysis of the current market trends from 2014 to 2022 to identify the prevailing opportunities . Market estimations provided in the report are based on comprehensive analysis of the key
2